Search - tctmd.com

Displaying 481 - 500 of 6061

Sort: Relevancy | Date

Presentation NY Valves 2025

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Presenter: Nirat Beohar

June 26, 2025

Presentation NY Valves 2025

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Management of Valve Balloon Rupture: a Case-Based Tutorial

Presenter: Itsik Ben-Dor

June 26, 2025

Presentation NY Valves 2025

LAAC in the Presence of Thrombus: When OAC Fails

Presenter: Brian P. O'Neill

June 26, 2025

Presentation NY Valves 2025

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Presenter: Takayuki Onishi

June 26, 2025

Presentation NY Valves 2025

Atrial FTR with a Favorable Anatomy for Tricuspid TEER

Presenter: Jennifer von Stein

June 26, 2025

Presentation NY Valves 2025

A Primer on Prevention and Management of Coronary Obstruction

Presenter: Dariusz Dudek

June 26, 2025

Presentation NY Valves 2025

A Lifetime of Mitral Management Misteries: Therapy Failure Modes and Disease Progression

Presenter: D. Scott Lim

June 26, 2025

Presentation NY Valves 2025

Transcatheter Closure of Sinus Venosus ASD With Partial Anomalous Pulmonary Venous Return: A 3D-Guided Approach

Presenter: Taha Hatab

June 26, 2025

Presentation NY Valves 2025

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Presenter: Chloe Kharsa

June 26, 2025

Presentation NY Valves 2025

Polymeric Devices for Better Longevity and Performance: PECA Labs

Presenter: Arush Kalra

June 26, 2025

Presentation NY Valves 2025

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Presenter: Matteo Sturla

June 26, 2025

Presentation NY Valves 2025

Case 4: Triple Valve Disease — Optimal Therapy Timing, Role of Surgery, and Staged Approaches

Presenter: Aakriti Gupta

June 26, 2025

Presentation NY Valves 2025

Clinical Programs’ Update: Key Insights and Lessons Learned from TMVR EFS

Presenter: Juan F. Granada

June 26, 2025

Presentation NY Valves 2025

Multiple ASD Closure Using the Interleaving Method: A Refined Strategy Utilizing Gore Cardioform Occluder Devices

Presenter: Bryan P. Traynor

June 26, 2025

Presentation NY Valves 2025

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Presenter: Yasemin Ciftcikal

June 26, 2025

Presentation NY Valves 2025

Hospital Performance on 30-Day Readmissions After Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry

Presenter: Dhaval Kolte

June 26, 2025

Presentation NY Valves 2025

Extracellular Matrix for Tricuspid Valve Replacement: Corvivo Cardiovascular

Presenter: John Engels

June 26, 2025

Presentation NY Valves 2025

Case 3: Concomitant MR and TR — Staged, Hybrid, Robotic, and Medical Therapy Options

Presenter: Parasuram Krishnamoorthy

June 26, 2025

Presentation NY Valves 2025

Case 2: Bicuspid Aortic Valve With Aortopathy

Presenter: Mahesh V. Madhavan

June 26, 2025

Advertisement

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Management of Valve Balloon Rupture: a Case-Based Tutorial

LAAC in the Presence of Thrombus: When OAC Fails

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Atrial FTR with a Favorable Anatomy for Tricuspid TEER

A Primer on Prevention and Management of Coronary Obstruction

A Lifetime of Mitral Management Misteries: Therapy Failure Modes and Disease Progression

Transcatheter Closure of Sinus Venosus ASD With Partial Anomalous Pulmonary Venous Return: A 3D-Guided Approach

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Polymeric Devices for Better Longevity and Performance: PECA Labs

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Case 4: Triple Valve Disease — Optimal Therapy Timing, Role of Surgery, and Staged Approaches

Clinical Programs’ Update: Key Insights and Lessons Learned from TMVR EFS

Multiple ASD Closure Using the Interleaving Method: A Refined Strategy Utilizing Gore Cardioform Occluder Devices

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Hospital Performance on 30-Day Readmissions After Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry

Extracellular Matrix for Tricuspid Valve Replacement: Corvivo Cardiovascular

Case 3: Concomitant MR and TR — Staged, Hybrid, Robotic, and Medical Therapy Options

Case 2: Bicuspid Aortic Valve With Aortopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content